Epsilon M&A Deal Report - Analysis
Transaction Multiples for the Valuation of Private Companies
Biolix / Analysis
No EMAT :
112577
Announced Date :
20/12/2019
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Biolix
Target :
Analysis
Country :
France
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
Business Description :
Founded in 1976, Analysis Selarl owns and operates several medical laboratories in Vosges .
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 52
| Date | Acquirer | Target | Country | Multiples | See details |
| 05/04/2018 | Biorhin | Proxilab | France | ** | 112569 |
| 18/10/2019 | Biolia | Biorhin | France | *** | 112558 |
Source: Epsilon Research / EMAT
